Welcome to LookChem.com Sign In|Join Free

CAS

  • or

790667-68-4

Post Buying Request

790667-68-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

790667-68-4 Usage

Molecular Weight

309.41 g/mol

Structure

Piperidine derivative with a BOC (tert-butoxycarbonyl) protecting group and an aminophenoxy moiety

Usage

Intermediate in the synthesis of pharmaceuticals and agrochemicals

Physical State

White to off-white solid

Solubility

Soluble in organic solvents such as methanol, ethanol, and dichloromethane

Significance

Role in medicinal chemistry research, particularly in the development of new drugs and potential therapeutic agents

Check Digit Verification of cas no

The CAS Registry Mumber 790667-68-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,0,6,6 and 7 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 790667-68:
(8*7)+(7*9)+(6*0)+(5*6)+(4*6)+(3*7)+(2*6)+(1*8)=214
214 % 10 = 4
So 790667-68-4 is a valid CAS Registry Number.

790667-68-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(3-aminophenoxy)-2-tert-butylpiperidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names tert-butyl4-(3-aminophenoxy)piperidine-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:790667-68-4 SDS

790667-68-4Relevant articles and documents

ISOINDOLINONE COMPOUNDS

-

, (2021/04/17)

Disclosed herein is a compound or pharmaceutically acceptable salts or stereoisomers thereof of of formula I wherein X1 is linear or branched C1-6 alkyl, C3-6 cycloalkyl, -C1-6 alkyl C3-6 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, C1-6 alkyl C6-10 aryl, C1-6 alkyl 5-10 membered heteroaryl, wherein X1 is unsubstituted or substituted with one or more of halogen, linear or branched C1-6 alkyl, linear or branched C1-6 heteroalkyl, CF3, CHF2, -O-CHF2, -O-(CH2)2-OMe, OCF3, C1-6 alkylamino, -CN, -N(H)C(O)-C1- 6alkyl, -OC(O)-C1-6alkyl, -OC(O)-C1-4alkylamino, -C(O)O-C1-6alkyl, -COOH, - CHO, -C1-6alkylC(O)OH, -C1-6alkylC(O)O-C1-6alkyl, NH2, C1-6 alkoxy or C1-6 alkylhydroxy; X2 is hydrogen, C6-10 aryl, 5-10 membered heteroaryl, -O-(5-10 membered heteroaryl), 4-8 membered heterocycloalkyl, C1-4 alkyl 4-8 membered heterocycloalkyl, -O-(4-8 membered heterocycloalkyl), -O-C1-4 alkyl-(4-8 membered heterocycloalkyl), -OC(O)-C1-4alkyl-4-8 membered heterocycloalkyl or C6 aryloxy, wherein X2 is unsubstituted or substituted with one or more of linear or branched C1-6 alkyl, NH2, NMe2 or 5-6 membered heterocycloalkyl; n is 0, 1 or 2.

Substituted aminopyrimidine derivative, preparation method therefor and pharmaceutical application thereof

-

, (2016/10/07)

The invention relates to a substituted aminopyrimidine derivative as shown in general formula (I) and (II), an optical isomer, a pharmaceutically acceptable salt or co-crystallization thereof, a preparation method and application in preparation of tumor m

Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs)

Wang, Qiang,Liu, Feiyang,Wang, Beilei,Zou, Fengming,Chen, Cheng,Liu, Xiaochuan,Wang, Aoli,Qi, Shuang,Wang, Wenchao,Qi, Ziping,Zhao, Zheng,Hu, Zhenquan,Wang, Wei,Wang, Li,Zhang, Shanchun,Wang, Yuexiang,Liu, Jing,Liu, Qingsong

, p. 3964 - 3979 (2016/05/19)

c-KIT kinase is a validated drug discovery target for gastrointestinal stromal tumors (GISTs). Clinically used c-KIT kinase inhibitors, i.e., Imatinib and Sunitinib, bear other important targets such as ABL or FLT3 kinases. Here we report our discovery of

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 790667-68-4